ANIXA BIOSCIENCES INC (ANIX) vs VAXART, INC. (VXRT)

ANIXA BIOSCIENCES INC and VAXART, INC. are both Biotechnology companies. ANIXA BIOSCIENCES INC and VAXART, INC. are of similar size ($96.6M and $92.4M). ANIXA BIOSCIENCES INC has negative trailing earnings, so its P/E is not meaningful; VAXART, INC. trades at 2.8×. VAXART, INC. grew revenue faster over the last twelve months: 201.1% against −34.1%. VAXART, INC. has the higher net margin (15.9% vs 0.00%) and the higher return on invested capital (134.6% vs 0.00%). Across the 17 metrics below, VAXART, INC. leads on 16 and ANIXA BIOSCIENCES INC on 1.

Valuation

Metric ANIX VXRT Biotechnology median
P/E n/m 2.81 7.88
P/S 97.76 0.45 11.47
P/B 7.20 1.32 2.52
Price to free cash flow n/m 3.26 21.16
EV/EBITDA n/m 1.49 0.74
EV/Sales 85.36 0.28 10.73
Earnings yield (11.51%) 35.56% (28.84%)
Free cash flow yield (7.73%) 30.65% (23.03%)

Profitability

Metric ANIX VXRT Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 16.30% 0.00%
Net margin 0.00% 15.88% 0.00%
Free cash flow margin 0.00% 13.74% 0.00%
Return on equity (72.57%) 66.97% (57.72%)
Return on assets (63.45%) 23.44% (49.22%)
Return on invested capital 0.00% 134.59% 0.00%

Growth

Metric ANIX VXRT Biotechnology median
Revenue growth (TTM) (34.10%) 201.10% 5.64%
EPS growth (last fiscal year) 12.82% 121.21% —
Revenue growth, 5-year CAGR (6.89%) 125.76% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANIX VXRT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.55 1.60 4.73
Net debt to EBITDA 1.29 (2.42) 0.96

Dividend

Metric ANIX VXRT Biotechnology median
Dividend yield — 3.63% 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ANIX VXRT Biotechnology median
Market cap 96.64m 92.41m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack